Related references
Note: Only part of the references are listed.Efficacy of omega-3-rich Camelina sativa on the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, controlled trial
Vali Musazadeh et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2022)
Effectiveness of omega-3 and prebiotics on adiponectin, leptin, liver enzymes lipid profile and anthropometric indices in patients with non-alcoholic fatty liver disease: A randomized controlled trial
Mahdieh Abbasalizad Farhangi et al.
JOURNAL OF FUNCTIONAL FOODS (2022)
Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force
Maurizio Averna et al.
ATHEROSCLEROSIS (2021)
Effects of dietary eicosapentaenoic acid and docosahexaenoic acid supplementation on metabolic syndrome: A systematic review and meta-analysis of data from 33 randomized controlled trials
Hui-Jun Zhang et al.
CLINICAL NUTRITION (2021)
Omega 3-rich Camelina sativa oil in the context of a weight loss program improves glucose homeostasis, inflammation and oxidative stress in patients with NAFLD: A randomised placebo-controlled clinical trial
Vali Musazadeh et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)
Efficacy of omega-3 fatty acid supplementation on cardiovascular risk factors in patients with polycystic ovary syndrome: a systematic review and meta-analysis
Yidan Xia et al.
ANNALS OF PALLIATIVE MEDICINE (2021)
The effects of omega-3 fatty acids on diabetic nephropathy: A meta-analysis of randomized controlled trials
Api Chewcharat et al.
PLOS ONE (2020)
Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation on Non-Alcoholic Fatty Liver: A Systematic Review and Meta-Analysis
Cheng-Han Lee et al.
NUTRIENTS (2020)
Omega-3 index and blood pressure responses to eating foods naturally enriched with omega-3 polyunsaturated fatty acids: a randomized controlled trial
Alice V. Stanton et al.
SCIENTIFIC REPORTS (2020)
The Anti-Inflammatory and Antioxidant Properties of n-3 PUFAs: Their Role in Cardiovascular Protection
Francesca Oppedisano et al.
BIOMEDICINES (2020)
Effects of EPA and DHA on blood pressure and inflammatory factors: a meta-analysis of randomized controlled trials
Xiao-fei Guo et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2019)
Health effects of dietary risks in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Ashkan Afshin et al.
LANCET (2019)
Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta-analysis of randomised placebo-control human clinical trials
S. Abu Mweis et al.
JOURNAL OF HUMAN NUTRITION AND DIETETICS (2018)
Omega-3 polyunsaturated fatty acids favourably modulate cardiometabolic biomarkers in type 2 diabetes: a meta-analysis and meta-regression of randomized controlled trials
Lauren L. O'Mahoney et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Risk of stroke and coronary heart disease among various levels of blood pressure in diabetic and nondiabetic Chinese patients
Yuqing Zhang et al.
JOURNAL OF HYPERTENSION (2018)
Systematic review and meta-analysis of controlled intervention studies on the effectiveness of long-chain omega-3 fatty acids in patients with nonalcoholic fatty liver disease
Kathy Musa-Veloso et al.
NUTRITION REVIEWS (2018)
Effect of omega-3 supplements on plasma apolipoprotein C-III concentrations: a systematic review and meta-analysis of randomized controlled trials
Amirhossein Sahebkar et al.
ANNALS OF MEDICINE (2018)
High Resolution Spatial Mapping of Human Footprint across Antarctica and Its Implications for the Strategic Conservation of Avifauna
Luis R. Pertierra et al.
PLOS ONE (2017)
The ratio of serum n-3 to n-6 polyunsaturated fatty acids is associated with diabetes mellitus in patients with prior myocardial infarction: a multicenter cross-sectional study
Masao Takahashi et al.
BMC CARDIOVASCULAR DISORDERS (2017)
Long-Chain Omega-3 Fatty Acids Eicosapentaenoic Acid and Docosahexaenoic Acid and Blood Pressure: A Meta-Analysis of Randomized Controlled Trials
Paige E. Miller et al.
AMERICAN JOURNAL OF HYPERTENSION (2014)
The limited effect of omega-3 polyunsaturated fatty acids on cardiovascular risk in patients with impaired glucose metabolism: A meta-analysis
Tengfei Zheng et al.
CLINICAL BIOCHEMISTRY (2014)
Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys
Renata Micha et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Short-term effects of fish-oil supplementation on heart rate variability in humans: a meta-analysis of randomized controlled trials
Wei Xin et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2013)
The anti-arrhythmic effects of n-3 PUFAs
Leonardo Calo et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence
Silvia Lorente-Cebrian et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2013)
Omega-3 fatty acids lower blood pressure by directly activating large-conductance Ca2+-dependent K+channels
Toshinori Hoshi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A systematic review of fish-oil supplements for the prevention and treatment of hypertension
Fiona Campbell et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2013)
Effect of omega-3 fatty acids supplementation on endothelial function: A meta-analysis of randomized controlled trials
Qianqian Wang et al.
ATHEROSCLEROSIS (2012)
The Effect of n-3 Polyunsaturated Fatty Acids on Plasma Lipids and Lipoproteins in Patients With Chronic Renal Failure-A Meta-Analysis of Randomized Controlled Trials
Jiao Pei et al.
JOURNAL OF RENAL NUTRITION (2012)
Dietary α-Linolenic Acid Inhibits Arterial Thrombus Formation, Tissue Factor Expression, and Platelet Activation
Erik W. Holy et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Do long-chain n-3 fatty acids reduce arterial stiffness? A meta-analysis of randomised controlled trials
Matthew P. Pase et al.
BRITISH JOURNAL OF NUTRITION (2011)
Omega-3 polyunsaturated fatty acids and heart rate variability
Jeppe Hagstrup Christensen
FRONTIERS IN PHYSIOLOGY (2011)
Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
M. R. Law et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
How relevant is the ratio of dietary n-6 to n-3 polyunsaturated fatty acids to cardiovascular disease risk? Evidence from the OPTILIP study
Bruce A. Griffin
CURRENT OPINION IN LIPIDOLOGY (2008)
Fish oil treatment for kidney transplant recipients: A meta-analysis of randomized controlled trials
Andy K. H. Lim et al.
TRANSPLANTATION (2007)
The effect of n-3 PUFA on eNOS activity and expression in Ea hy 926 cells
Aurelie Gousset-Dupont et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2007)
n-3 (omega-3) polyunsaturated fatty acids prevent acute atrial electrophysiological remodeling
D. N. Q. da Cunha et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Cardioprotective prostacyclin signaling in vascular smooth muscle
Kristina M. Fetalvero et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2007)
Eicosapentaenoic acid modifies lipid composition in caveolae and induces translocation of endothelial nitric oxide synthase
Qiurong Li et al.
BIOCHIMIE (2007)
Effects of endurance training on blood pressure, blood pressure-regulating mechanisms, and cardiovascular risk factors
VA Cornelissen et al.
HYPERTENSION (2005)
Global burden of hypertension: analysis of worldwide data
PM Kearney et al.
LANCET (2005)
Achieving optimal essential fatty acid status in vegetarians: current knowledge and practical implications
BC Davis et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2003)
Share Paper
